[Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus]

Infez Med. 2001 Sep;9(3):163-9.
[Article in Italian]

Abstract

Objective: To evaluate the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus (MRSA).

Methods: Analysis of the incidence of infection and contamination due to MRSA in patients admitted to the hospital of Cremona 6 months before and 3 years after the introduction of the guidelines (July 1997).

Results: During the 42 months of the study period, on 80705 admissions, 511 cases of MRSA contamination/infection were identified, the incidence being 0.57 cases per 100 admissions. The infection rate dropped from 0.34 (IC95%: 0.25-0.45) in the first 6 months of the study, before the introduction of guidelines, to 0.17 (IC95%: 0.14-0.20) in the following 3 years (p=0.01). Severe infection decreased from 0.18 to 0.1 per 100 admissions, with a 44% decrease (p=0.058), while mild infections diminished from 0.16 to 0.07 per 100 admissions (p=0.045). Methicillin resistance among nosocomial isolates of Staphylococcus aureus was reduced from 53 % to 35 % (p<0.0001).

Conclusions: The introduction of a program to control the nosocomial spread of MRSA proved effective in reducing both the incidence of infection and the methicillin-resistance of Staphylococcus aureus isolates. The cost effectiveness of the program seems very favourable.

Publication types

  • Evaluation Study

MeSH terms

  • Body Fluids / microbiology
  • Carrier State / epidemiology
  • Cost-Benefit Analysis
  • Cross Infection / economics
  • Cross Infection / epidemiology
  • Cross Infection / prevention & control*
  • Diagnostic Tests, Routine
  • Hospitals, Urban / economics
  • Hospitals, Urban / statistics & numerical data
  • Humans
  • Incidence
  • Infection Control / economics
  • Infection Control / organization & administration*
  • Infection Control / statistics & numerical data
  • Italy / epidemiology
  • Methicillin Resistance*
  • Patient Isolation
  • Patients' Rooms
  • Practice Guidelines as Topic
  • Program Evaluation
  • Risk Factors
  • Seasons
  • Specimen Handling
  • Staphylococcal Infections / economics
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification